Drugs & Toxicology Flashcards
Reasons for TDM (drug factors) (5)
- overdose s/s similar to disease being treated
- very toxic in overdose
- narrow therapeutic index
- wide variation of therapeutic index (e.g. by variable pharmacokinetics, underlying conditions, DDI)
- ensure efficacy of the drug
Indications to start TDM (patient factors) (5)
- initiation / change of dosage
- suboptimal response despite compliance
- loss of control in previously stable patient
- additional drugs are given / polypharmacy
- confirm clinical diagnosis of toxicity
How many half-lives are required for a drug to reach steady-state concentration?
5 (so blood sampling should be taken afterwards)
Factors leading to a high / abnormal drug level (5)
- change in the form of medication –> affect bioavailability
- wrong dosage
- wrong sampling
- impaired excretion (e.g. renal impairment)
- DDI
Reasons for TDM for gentamicin (2)
- half-life is prolonged in renal impairment (2~3h to up to 100h)
- nephrotoxicity similar to GN septicaemia
TDM inclusion criteria for gentamicin (4)
- abnormal RFT
- > 60y
- concurrent use of nephrotoxic medication / contrast medium
- duration of planned therapy >5~7d
Sampling time for TDM of gentamicin
6~14h post-dose
What is the graph used to determine dosing interval of gentamicin?
Hartford nomogram
Reasons for TDM of phenytoin (3)
- non-linear dose-concentration curve (narrow therapeutic index)
- variable pharmacokinetics
(a) CYP substrate
(b) highly protein binding - CNS toxicity
Why TDM of phenytoin is indicated in pregnancy?
pregnancy –> ↑ protein level –> ↓ pheytoin conc. as it is highly protein bound
Sampling time for TDM of cyclosporine (what sample is taken?)
- C0 (pre-dose)
- C2 (2h post-dose)
(whole blood)
Therapeutic range of digoxin (HF and arrhythmia)
HF: 0.6~1.3
Arrhythmia: 1.2~2.6
When is digoxin effect potentiated? (4)
hypoK, hyperCa, hypoMg, hypothyroidism
DDI between digoxin and…
(a) Amiodarone
(b) Antibiotics
amiodarone –> ↓ elimination of digoxin
antibiotics –> ↓ gut metabolism of digoxin –> ↑ oral availability
Reasons for TDM of cyclosporine (4)
- narrow therapeutic index
- therapeutic index varying with organ transplanted and time from transplantation
- renal & hepatic toxicity mimic graft rejection
- ensure efficacy of drug
Reasons for TDM of digoxin (4)
- narrow therapeutic index
- conc. greatly varied by electrolytes
- toxicity (n/v, anorexia, colour vision distortion, arrhythmia) mimics chronic HF
- DDI (amiodarone, antibiotics)
Sampling time for digoxin
6h post-dose
Management of digoxin overdose (2)
digibind
correct electrolyte disturbance